GDUFA Research Outcomes
PBPK Models
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to physiologically-based pharmacokinetics (PBPK) computational modeling to support generic product development and assessment.
-
Ocular PBPK/PD Modeling to Explore In Vitro Bioequivalence Approach for Brinzolamide Ophthalmic Suspensions
Tan, Mingliang
-
AI for Augmenting and Accelerating Computational Fluid Dynamics Predictions of Regional Lung Deposition
Walenga, Ross
-
Formulations in Flux: Simulating the Effect of Dynamic Formulation Composition Changes Following Application of Complex Topical Drug Products
Clarke, James
-
The Development and Framework of Model Master Files as a Regulatory Initiative
Tsakalozou, Eleftheria
-
Recommendations for Demonstrating Bioequivalence of Nasal Sprays: Scientific Thinking and Regulatory Research
Boc, Susan
-
Evaluating Charcoal Block Pharmacokinetics as a Surrogate for Regional Lung Drug Delivery in Orally Inhaled Drug Products
Walenga, Ross; Feng, Kairui (Kevin); Hu, Meng; Babiskin, Andrew
-
Model Integrated Evidence and Model Master File for Developing Orally Inhaled Drug Products
Walenga, Ross
-
Quantitative Studies to Inform PSG Development for Tiotropium Bromide Inhalation Spray, Metered
Chopski, Steven; Babiskin, Andrew; Newman, Bryan; Dhapare, Sneha; Boc, Susan; Kakhi, Maziar; Walenga, Ross
-
Adopting the Model Master File Framework to Enhance Modeling and Simulations Approaches for Regulatory Use
Fang, Lanyan (Lucy)
-
Advancing In Silico Methods and Future Opportunities for Understanding Impact of Compositional Differences on Performance
Walenga, Ross